Please login to Zacks.com or register to post a comment.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| SCIENTIFIC L | SCIL | 8.00% |
| NATUS MEDICA | BABY | 6.11% |
| SUMMER INFAN | SUMR | 6.02% |
| RADIANT LOGI | RLGT | 5.32% |
| NEW ORIENTAL | EDU | 4.51% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
Houston, Texas-based Marathon Oil Corporation ( MRO - Analyst Report ) plans to sell its natural gas-rich acreage in the Marcellus Shale formation as it aims to shed the non-core properties while reviewing its portfolio following last year's spin-off of its refining division. However, the company declined to comment on any such transaction.
A leading integrated oil and gas firm − Marathon − will likely shed about 80,000 acres in West Virginia and Pennsylvania and could receive up to $1,000 an acre. The company now considers its Marcellus assets as non-core and minor to its operations.
Marathon had drilled its first well in the Marcellus region sometime back in 2009. Last year, the company entered into a joint venture agreement with an independent oil and gas exploration company, Triana Energy Investments LLC, backed by Morgan Stanley Private Equity, for the development of its acreage in the region.
However, in response to the low gas price environment, Marathon and other energy giants are focusing more on liquid-rich profitable areas. A supply glut has resulted in cascading natural gas prices during the past year or so, as production from dense rock formations (shale) - through novel techniques of horizontal drilling and hydraulic fracturing - remains robust. The grossly oversupplied market continues to pressure commodity prices in the backdrop of sustained strong production.
Again, in July 2011, Marathon completed the spin-off of its refining/sales business into a separate, independent and publicly traded company Marathon Petroleum Corporation ( MPC - Analyst Report ) . We believe the transfer of the downstream assets (post-split) has left Marathon with a less diversified business. As a result, the business risk profile of the reorganized Marathon is weaker than that of the pre-spin-off company. Hence, this divestiture of non-core assets will likely reflect its endeavor to reposition its portfolio post spin-off.
We maintain our long-term Neutral recommendation on Marathon shares, which currently retains a Zacks #3 Rank (short-term Hold rating).
Read the full reports :
Analyst Report on MRO
Analyst Report on MPC